Porque fechamos os olhos enquanto o mundo cai ? Um estudo sobre fracturas osteoporóticas do fémur proximal numa população portuguesa

Acta Reumatologica Portuguesa

Volumn 34, Issue 2 B, 2009, Pages 370-377

  Cruz, Margarida ^a  

^a Centro Hospitalar das Caldas da Rainha   (Portugal)

Author keywords

Falls; Osteoporosis; Osteoporotic fracture; Prevention.; Treatment

Indexed keywords

AGED; ARTICLE; FEMALE; HIP FRACTURE; HUMAN; MALE; MIDDLE AGED; OSTEOPOROSIS; PATHOLOGIC FRACTURE; PORTUGAL; RETROSPECTIVE STUDY;

AGED; AGED, 80 AND OVER; FEMALE; FRACTURES, SPONTANEOUS; HIP FRACTURES; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; PORTUGAL; RETROSPECTIVE STUDIES;

EID: 79958110400     PISSN: 0303464X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis and Therapy. Osteoporosis prevention, diagnosis and therapy. JAMA 2001; 285: 785-795
2. Kanis JA. Diagnosis of osteoporosis and assessment of fracture risk. Lancet 2002; 359: 1929-1936
3. Jalava T, Sarna S, Pylkkanen L, Mawer B et al. Association between vertebral fracture and increased mortality in osteoporotic patients. J Bone Min Res 2003; 18: 1254-1260
4. Black DM, Cummings SR, Karpf DB et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture intervention trial research group. Lancet 1996; 348: 1535-1541
5. Ettinger B, Black DM, Mitlak BH et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple outcomes of raloxifene evaluation (MORE) investigators. JAMA 1999; 282: 637-645
6. Reginster J, Minne HW, Sorensen OH et al. Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral efficacy with risedronate therapy (VERT) study group, Osteoporos Int 2000; 11: 83-91
7. Neer RM, Arnaud CD, Zanchetta JR et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 2001; 344: 1434-1441
8. Reginster JY, Adami S, Lakatos P et al. Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study. Ann Rheum Dis 2006; 65: 654-661
9. Black DM, Delmas PD, Eastell R et al. Once-Yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med 2007; 356: 1809-1822
10. Kanis JA, Borgstrom F, De Laet C et al. Assessment of fracture risk. Osteoporos Int 2005; 16: 581-589
11. Roux C. Ostéoporose: un objectif prioritaire, réduire le nombre de fractures. Presse Med 2006;35: 1527-1528
12. Melton III LJ, Kanis JA, Johnell O. Potential impact of osteoporosis treatment on hip fracture trends. J Bone Min Res 2005; 20: 895-897
13. Tosteson ANA, Grove MR, Hammond CS et al. Early discontinuation of treatment for osteoporosis. Am J Med 2003; 115: 209-216
14. Papaioannou A, Joannidis G, Adachi JD et al. Adherence to bisphosphonates and hormone replacement therapy in a tertiary care setting of patients in the CANDOO database. Osteoporos Int 2003; 14: 808-813
15. Rubenstein LZ, Josephson KR. Falls and their prevention in elderly people: what does the evidence show? Med Clin N Am 2006; 90: 807-824
16. Magaziner J, Simonsick EM, Kashner TM et al. Predictors of functional recovery one year following hospital discharge for hip fracture: a prospective study. J Gerontol 1990; 45:101-107
17. Rao SS. Prevention of falls in older patients; Am Fam Physician 2005; 72: 81-88
18. Ganz DA, Bao Y, Shekelle PG, Rubenstein LZ. Will my patient fall?; JAMA 2007; 297: 77-86
19. Campbell AJ, Robertson MC, Gardner MM, Norton RN, Buchner DM. Psychotropic medication withdrawal and a home-based exercise program to prevent falls: a randomized, controlled trial. J Am Geriatr Soc 1999; 47: 850-853
20. Kannus P, Sievanen H, Palvanen M, Jarvinen P, Parkkari J. Prevention of falls and consequent injuries in elderly people; Lancet 2005; 366: 1885-1893
21. Nnodim JO, Alexander NB; Assessing falls in older adults - a comprehensive fall evaluation to educe fall risk in older adults. Geriatrics 2005; 60: 24-28
22. Bischoff HA, Stahelin HB, Dick W et al. Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial. J Bone Min Res 2003; 18: 343-351
23. Bishoff-Ferrari HA, Orav JE, Dawson-Hughes B; Effect of vitamin D plus calcium on fall risk in older men and women: a 3-year randomized controlled trial. J Bone Min Res 2004; 19:S57
24. Harwood RH, Sahota O, Gaynor K, Masud T, Hosking DJ. A randomised, controlled comparison of different calcium and vitamin D supplementation regimens in elderly women after a hip fracture: The Nottingham neck of femur (NONOF) study. Age Ageing 2004; 33: 45-51
25. Dukas L, Bischoff HA, Lindpaintner LS et al. Alfacalcidiol reduces the number of fallers in a communitydwelling elderly population with a minimum calcium intake of more than 500 mg daily. J Am Geriatr Soc 2004; 52: 230-236
26. Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC et al. Effect of vitamin D on falls: a meta-analysis. JAMA 2004; 291: 1999-2006
27. Porthouse J, Cockayne S, King C et al. Randomised controlled trial of supplementation with calcium and cholecalciferol (vitamin D3) for prevention of fractures in primary care. BMJ 2005; 330: 1003-1006
28. The RECORD trial group. Oral vitamin D and calcium for secondary prevention of low-trauma fractures in elderly people (randomized evaluation of calcium or vitamin D, RECORD: a randomised placebo-controlled trial). Lancet 2005; 365: 1621-1628
29. Parker MJ, Gillespie LD, Gillespie WJ. Hip protectors for preventing hip fractures in the elderly. Cochrane database systematic review 2001 (2): CD 001255
30. Melton III LJ. Epidemiology of Fractures. In: Riggs BL, Melton III LJ, eds. Osteoporosis: etiology, diagnosis and management. New York: Raven Press; 1988: 133--154
31. Gallagher JC, Melton LJ, Riggs BL, Bergstrath E. Epidemiology of fractures of the proximal femur in Rochester, Minnesota. Clin Orthop Rel Res. 1980; 163-171
32. Mendes E, Abrantes A, Nelas J, Leirinha M. Fracturas da extremidade superior do fémur num Hospital Distrital. Breve análise estatística. Acta Reum Port 2000; 25 (99): 21-24
33. Salvador MJ, Ferreira A, Gomes C, Moniz T, Judas F. Fracturas da extremidade superior do fémur - morbilidade e mortalidade. Acta Reum Port 2002; 27 (2): 91-100
34. Pina MF, Alves SM, Barbosa M, Barros H. Hip fractures cluster in space: an epidemiological analysis in Portugal. Osteoporos Int 2008; 19: 1797-1804
35. Johnell O, Kanis J. Epidemiology of osteoporotic fractures. Osteoporosis Int 2005; 16: S3-7
36. Mateus MM, Cruz CM, Alves de Matos AC, Branco JC. Hospital care costs of osteoporotic hip fractures - comparative study with other prevalent diseases; Osteoporosis International, Apr 2002; vol. 13 (suppl 1): S 75 (P238SU)
37. Branco JC, Alves de Matos AC. Custos hospitalares das fracturas osteoporóticas do colo do fémur. Estudo comparativo com outras doenças não transmissíveis; Acta Reum Port 1995; 72: 7-22
38. Tavares V, Canhão H, Melo Gomes JA et al. Recomendações para o diagnóstico e terapêutica da osteoporose. Acta Reum Port 2007; 32: 49-59
39. Kanis JA, Burlet N, Cooper C et al. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 2008; 19: 399-428
40. Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E. FRAX ™ and the assessment of fracture probability in men and women from the UK. Osteoporos Int 2008; 19: 385-397